Position in MDCX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$148,817
+$56,502 QoQ
Shares Held
333,673
+453.0% QoQ
Ownership
0.528%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 23 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDCX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,179,497,111 across 15 Drug Manufacturers - General names. MDCX ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
458,318 | $549,720,403 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
1,246,545 | $157,488,493 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,121,026 | $144,051,841 | |
| 4 | JNJ |
Johnson & Johnson
|
382,411 | $97,120,920 | |
| 5 | ABBV |
AbbVie Inc.
|
349,226 | $87,879,230 | |
| 6 | PFE |
Pfizer Inc
|
3,234,701 | $77,891,599 | |
| 7 | GSK |
GSK plc
|
551,413 | $28,905,069 | |
| 8 | AMGN |
Amgen Inc
|
34,309 | $12,423,973 |
All Filings in MDCX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $148,817 | 333,673 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $92,315 | 60,337 | Shares | Defined | 2026-02-12 | |
| 2025-06-30 | $41,226 | 13,788 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||